Minirin (Desmopressin Acetate)

Desmopressin Acetate, the active ingredient in Minirin, is a vasopressin analog presented as a nasal spray for nasal use. It selectively increases water reabsorption in the kidneys and is indicated for the management of central diabetes insipidus and nocturnal enuresis in patients requiring antidiuretic therapy.

GNH USA supplies Minirin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to quality‑assured medicines across regulated markets. Our distribution network ensures timely delivery and compliance with local regulatory requirements.

Desmopressin acetate (Minirin) is used to treat disorders of water balance that involve deficient antidiuretic hormone activity.

- Central diabetes insipidus: restores water reabsorption and reduces excessive urine output. - Nocturnal enuresis: decreases nighttime urine production and improves bladder control. - Primary nocturnal enuresis in children: reduces bedwetting episodes by limiting overnight diuresis.

Desmopressin acetate may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Nasal irritation or burning - Headache - Mild hyponatremia - Nausea

Serious or Rare Side Effects: - Severe hyponatremia leading to seizures or coma - Allergic reaction such as rash, swelling, or anaphylaxis - Nasal septum perforation with prolonged use

When prescribing or using Minirin, consider the following precautions.

- Assess fluid balance: monitor serum sodium and daily fluid intake. - Avoid excessive water intake: limit free water to reduce hyponatremia risk. - Use with caution in renal impairment: increase monitoring of electrolytes. - Pregnancy and lactation: safety not established; evaluate risk‑benefit with a clinician. - Store at room temperature: keep in original container, protect from moisture and light.

Desmopressin acetate can interact with several medicines; categorize them by clinical significance.

Major Interactions (Avoid): - Carbamazepine: may reduce desmopressin efficacy. - Thiazide diuretics: increase risk of hyponatremia. - Other antidiuretic agents: additive water‑retaining effect.

Moderate Interactions (Monitor Closely): - NSAIDs: may enhance antidiuretic activity. - SSRIs: potential for hyponatremia. - Alcohol: may increase risk of water intoxication.